4 Non-contrast assessment of myocardial viability in chronic myocardial infarction by native T1 and T2 mapping at 1.5T CMR: comparison with late gadolinium enhancement technique. (18th May 2017)
- Record Type:
- Journal Article
- Title:
- 4 Non-contrast assessment of myocardial viability in chronic myocardial infarction by native T1 and T2 mapping at 1.5T CMR: comparison with late gadolinium enhancement technique. (18th May 2017)
- Main Title:
- 4 Non-contrast assessment of myocardial viability in chronic myocardial infarction by native T1 and T2 mapping at 1.5T CMR: comparison with late gadolinium enhancement technique
- Authors:
- Dastidar, Amardeep Ghosh
Pontecorboli, Giulia
Harries, Iwan
Moret, Charlie
Morgan, Gareth
Garate, Estefania De
Baritussio, Anna
Bucciarelli-Ducci, Chiara - Abstract:
- Abstract : Background: Viability assessment is a key aspect in the management of ischaemic heart disease (IHD). Hypothesis: native T1 and T2 mapping can assess myocardial viability without the use of gadolinium. Methods: 30 patients with known MI (>5yrs from MI) and 20 normal healthy controls underwent conventional 1.5T CMR to assess LV function and the presence and extent of myocardial infarction (scar transmurality) using a scale of 0–4 for the 16 AHA segment (0=no scar, 1=1–24%, 2=25–49%, 3=50–74% and 4 ≥75% scar thickness). Segments with <50% LGE was considered viable. LGE viability was compared with the corresponding native segmental T1 and T2 obtained from T1 maps (MOLLI sequence, motion corrected) and T2 maps. Results: 800 myocardial segments were analysed (320-healthy controls, 480-MI patients). The mean segmental T1 and T2 values for scar transmurality grade 0–4 were 1031±31 ms, 1070±33 ms, 1103±32 ms, 1164±58 ms, 1206±118 ms (p<0.001) and 52±4 ms, 55±4 ms, 58±5 ms, 59±8 ms, 66±9 ms (p<0.001) respectively in chronic MI. ROC analysis of 480 ?segments in chronic MI showed that for myocardial viability assessment, native T1-mapping demonstrated excellent diagnostic performance compared to LGE as the gold standard (AUC-0.94, 95%CI 0.89–0.99, p<0.0001). Native T1 mapping also had the highest diagnostic accuracy for viability assessment when compared to T2 mapping, LV wall thickness, regional wall motion abnormality. A T1 threshold of 1090ms best ?differentiated viableAbstract : Background: Viability assessment is a key aspect in the management of ischaemic heart disease (IHD). Hypothesis: native T1 and T2 mapping can assess myocardial viability without the use of gadolinium. Methods: 30 patients with known MI (>5yrs from MI) and 20 normal healthy controls underwent conventional 1.5T CMR to assess LV function and the presence and extent of myocardial infarction (scar transmurality) using a scale of 0–4 for the 16 AHA segment (0=no scar, 1=1–24%, 2=25–49%, 3=50–74% and 4 ≥75% scar thickness). Segments with <50% LGE was considered viable. LGE viability was compared with the corresponding native segmental T1 and T2 obtained from T1 maps (MOLLI sequence, motion corrected) and T2 maps. Results: 800 myocardial segments were analysed (320-healthy controls, 480-MI patients). The mean segmental T1 and T2 values for scar transmurality grade 0–4 were 1031±31 ms, 1070±33 ms, 1103±32 ms, 1164±58 ms, 1206±118 ms (p<0.001) and 52±4 ms, 55±4 ms, 58±5 ms, 59±8 ms, 66±9 ms (p<0.001) respectively in chronic MI. ROC analysis of 480 ?segments in chronic MI showed that for myocardial viability assessment, native T1-mapping demonstrated excellent diagnostic performance compared to LGE as the gold standard (AUC-0.94, 95%CI 0.89–0.99, p<0.0001). Native T1 mapping also had the highest diagnostic accuracy for viability assessment when compared to T2 mapping, LV wall thickness, regional wall motion abnormality. A T1 threshold of 1090ms best ?differentiated viable from non-viable segments with a sensitivity of 90% and specificity of 91%. Conclusions: Native T1 mapping can differentiate between normal, viable, and non-viable myocardium with distinctive T1 profiles in chronic MI without the need for gadolinium. … (more)
- Is Part Of:
- Heart. Volume 103(2017)Supplement 4
- Journal:
- Heart
- Issue:
- Volume 103(2017)Supplement 4
- Issue Display:
- Volume 103, Issue 4 (2017)
- Year:
- 2017
- Volume:
- 103
- Issue:
- 4
- Issue Sort Value:
- 2017-0103-0004-0000
- Page Start:
- A2
- Page End:
- A2
- Publication Date:
- 2017-05-18
- Subjects:
- Heart -- Diseases -- Treatment -- Periodicals
Cardiology -- Periodicals
616.12 - Journal URLs:
- http://www.bmj.com/archive ↗
http://heart.bmj.com ↗
http://www.heartjnl.com ↗ - DOI:
- 10.1136/heartjnl-2017-311677.4 ↗
- Languages:
- English
- ISSNs:
- 1355-6037
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18520.xml